Compare ELVN & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
| Metric | ELVN | IRS |
|---|---|---|
| Founded | 2016 | 1943 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 1994 |
| Metric | ELVN | IRS |
|---|---|---|
| Price | $15.81 | $15.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $41.20 | N/A |
| AVG Volume (30 Days) | ★ 708.2K | 171.8K |
| Earning Date | 11-12-2025 | 02-06-2026 |
| Dividend Yield | N/A | ★ 9.15% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $370,153,377.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.46 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.30 | $10.61 |
| 52 Week High | $25.37 | $17.23 |
| Indicator | ELVN | IRS |
|---|---|---|
| Relative Strength Index (RSI) | 30.93 | 50.34 |
| Support Level | $16.62 | $15.05 |
| Resistance Level | $20.47 | $15.76 |
| Average True Range (ATR) | 1.43 | 0.53 |
| MACD | -0.56 | -0.07 |
| Stochastic Oscillator | 2.49 | 48.50 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.